Medical oncology and Precision Medicine

All Items

• Treatment of neuropathic pain in cancer survivors: a scoping review of pharmacological, exercise, and psychosocial interventions

  Ellen Lund Schaldemose, Bolette Skjødt Rafn, Pernille Envold Bidstrup, Agon Olloni, Katrin Schättiger, Peter Christensen, Cæcilie Borregaard Myrhøj, Maja Johannsen Lindberg, Christoffer Johansen, Sandra Jensen, Ida Hovdenak, Sasja Jul Håkonsen, Lise Ventzel

  333-343

• Multidisciplinary team meetings for lung cancer in the Nordic countries: results from a Nordic survey

  Anja Gouliaev, Janna Berg, Johan Isaksson, Heidi Andersén, Torben Riis Rasmussen

  301-305

• FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework

  Edvard Abel, Päivi Östling, Ebba Hallersjö Hult, Katarzyna Kulbacka, Haris Babacic, Annika Baan, Ana Carneiro, Luigi De Petris, Henrik Fagman, Signe Friesland, Oskar Frisell, Mats Hellström, Gabriel Lindahl, Katarina Steen Carlsson, David Tamborero, Antonios Valachis, Daniel Öhlund, Janne Lehtiö, Richard Rosenquist, Anders Edsjö

  268-272

• Targeted therapy in the treatment of lung cancer in Iceland 2010–2023

  Stefanía Ásta Tryggvadóttir, Guðlaugur V. Stefánsson, Helgi Birgisson, Örvar Gunnarsson, Tómas Guðbjartsson, Hrönn Harðardóttir, Bylgja Hilmarsdóttir, Rósa B. Barkardóttir, Sigurdis Haraldsdottir

  261-267

• Prevalence and risk factors for nausea and vomiting in breast cancer patients undergoing chemotherapy

  Yuhui Feng, Liushan Wei, Qinhong Zou, Xiaoyong Lei, Xiaoyan Yang

  252-260

• How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

  Frigg Å. Sommervoll, Henrik Horndalsveen , Dag Einar Sommervoll, Jussi Koivonen, Tarje Onsøien Halvorsen, Bjørn Henning Grønberg, Marianne Aanerud, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Gina Barrera, Maria M. Bjaanæs, Vilde Haakensen, Åsa Öjlert, Kersti Oselin, Åslaug Helland, Tesfaye Madebo

  232-240

• Merging clinical research and standard healthcare – Nordic Precision Cancer Medicine Symposium 2025

  Elisa Bjørgo, Nina Ånensen, Gro Live Fagereng, Hege G. Russnes, Sigbjørn Smeland, Kjetil Taskén, Åslaug Helland

  181-185

• ‘Crossing borders’ in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine

  Maria Martin Agudo, Henk van der Pol, Gabriel Bratseth Stav, Tina Kringelbach , Katarina Puco, Åsmund Flobak, Hans Gelderblom, Kjetil Taskén, Gro Live Fagereng, Eivind Hovig

  159-163

• Realising precision oncology through shared real-world data infrastructure

  Andreas Bjerrum, Andreas Fanø, Ulrik Lassen

  156-158

• Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer

  Meeri Maunu, Juho Lähteenmaa, Peeter Karihtala, Suvi Tuohinen, Joonas Laaksolilja, Anders Ståhls, Tuomo Meretoja, Johanna Mattson

  131-140